This systematic review and meta-analysis examines evidence regarding screening pathways incorporating magnetic resonance imaging with targeted biopsy and assess their diagnostic value compared with prostate-specific antigen–based screening with systematic biopsy strategies.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Trends in Prebiopsy MRI Utilization for Prostate Cancer Detection | 0 | 10.92 | 17-09-2026 |
| 2 | Prostate-Specific Membrane Antigen Imaging and Initial Treatment for Prostate Cancer | 0 | 10.24 | 01-07-2026 |
| 3 | Neoadjuvant Immune Checkpoint Inhibitors in Early Breast Cancer | 0 | 7.64 | 01-10-2024 |
| 4 | PFS in Metastatic Breast Cancer by Local Investigators vs Blinded Independent Central Review | 0 | 8.34 | 16-07-2026 |
| 5 | Race, Secondary Treatment, and Survival in Localized Prostate Cancer | 0 | 5.24 | 21-07-2026 |
| 6 | Prostate Cancer Mortality After Relabeling Low-Grade Prostate Cancer as Precancerous | 0 | 9.66 | 01-07-2026 |
| 7 | Total Thyroidectomy vs Lobectomy for Sporadic Medullary Thyroid Cancer | 0 | 7.74 | 01-04-2026 |
| 8 | Biopsia de próstata por fusión transperineal: una técnica avanzada para el diagnóstico del cáncer de próstata | 0 | 6.32 | 06-09-2026 |
| 9 | Circulating Tumor DNA in Early Breast Cancer | 0 | 9.02 | 01-07-2026 |
| 10 | Age-Dependent Interplay of Modifiable Risk Factors and Genetic Risk in Pancreatic Cancer | 0 | 7.57 | 01-07-2026 |